Stepwise progression of β-selection during T cell development as revealed by histone deacetylation inhibition
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
During T cell development, the first step in creating a unique T Cell Receptor (TCR) is the genetic recombination of the TCRβ chain. The quality of the newly recombined TCRβ is assessed at the β-selection checkpoint. Most cells fail this checkpoint and die, but the coordination of the complex events that control fate at the β-selection checkpoint is not yet understood. We shed new light on fate determination during β-selection using a selective inhibitor of histone deacetylase 6, ACY1215. ACY1215 disrupted the β-selection checkpoint. Characterising the basis for this disruption revealed a new, pivotal stage in β-selection, bookended by upregulation of the TCR co-receptors, CD28 and CD2 respectively. Within this ‘DN3b Pre’ stage, CD5 and Lef1 are upregulated to reflect pre-TCR signalling and their expression correlates with proliferation. During this phase, ACY1215-mediated disruption of the organisation of the β-selection immunological synapse is associated with a breakdown in connectivity of expression of pre-TCR, CD5 and Lef1. Subsequent deregulation of pre-TCR-induced proliferation leads to bypass of the β-selection checkpoint and subsequent failure to progress. We propose that the progressive expression of CD28, CD5 and Lef1, then CD2 reports and modulates the pre-TCR signal to orchestrate passage through the β-selection checkpoint. These findings suggest a refined model of β-selection in which a coordinated increase in expression of pre-TCR, CD28, CD5 and Lef1 allows for modulating TCR signalling strength, and culminates in the expression of CD2 to enable exit from the β-selection checkpoint.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (65)
- Pre-existing chromatin accessibility and gene expression differences among naïve CD4<sup>+</sup>T cells influence effector potential via crossref
- doi:10.1083/jcb.201908108 via crossref
- doi:10.2174/138161208786404335 via crossref
- doi:10.4049/jimmunol.166.9.5464 via crossref
- doi:10.1084/jem.188.12.2301 via crossref
- doi:10.1084/jem.190.10.1383 via crossref
- doi:10.4049/jimmunol.1801373 via crossref
- doi:10.4049/jimmunol.170.9.4623 via crossref
- doi:10.1042/bst20180414 via crossref
- doi:10.1242/jcs.235358 via crossref
- doi:10.1038/ni.3226 via crossref
- doi:10.3390/ijms19082337 via crossref
- doi:10.1182/blood-2006-02-005900 via crossref
- doi:10.1016/s0140-6736(00)02293-5 via crossref
- doi:10.1016/s0092-8674(00)81608-6 via crossref
- doi:10.1016/j.it.2021.06.005 via crossref
- doi:10.1084/jem.20170807 via crossref
- doi:10.1038/ni0901-863 via crossref
- doi:10.1182/blood-2005-01-0337 via crossref
- doi:10.1002/j.1460-2075.1992.tb05339.x via crossref
- doi:10.1038/ni1436 via crossref
- doi:10.1038/s41573-020-0077-5 via crossref
- doi:10.1101/pdb.prot5156 via crossref
- doi:10.1021/cb500838r via crossref
- doi:10.4049/jimmunol.155.8.3929 via crossref
- doi:10.1186/s40425-019-0517-0 via crossref
- doi:10.1126/science.abe0918 via crossref
- doi:10.1007/s00018-015-1864-8 via crossref
- doi:10.7554/elife.65435 via crossref
- doi:10.4049/jimmunol.165.12.7017 via crossref
- doi:10.1126/science.aas8995 via crossref
- doi:10.1073/pnas.1504971112 via crossref
- doi:10.1073/pnas.1922525117 via crossref
- doi:10.1038/ni.2590 via crossref
- doi:10.1016/j.immuni.2007.12.013 via crossref
- doi:10.1038/s41580-018-0081-3 via crossref
- doi:10.1126/sciimmunol.abb1662 via crossref
- doi:10.1083/jcb.201901099 via crossref
- doi:10.1084/jem.177.4.1079 via crossref
- doi:10.4049/jimmunol.166.4.2394 via crossref
- doi:10.1016/s1074-7613(04)00078-0 via crossref
- doi:10.1146/annurev-immunol-092719-082622 via crossref
- doi:10.1042/bj20140040 via crossref
- doi:10.1242/dev.192203 via crossref
- doi:10.1002/eji.202048788 via crossref
- doi:10.1038/nri1529 via crossref
- doi:10.1016/j.immuni.2005.11.012 via crossref
- doi:10.1126/science.7542801 via crossref
- doi:10.1093/intimm/dxq020 via crossref
- doi:10.1073/pnas.112212699 via crossref
- doi:10.1101/gad.5.5.880 via crossref
- doi:10.1016/j.jaci.2014.10.002 via crossref
- doi:10.3389/fimmu.2018.02900 via crossref
- doi:10.1186/s12943-019-1127-7 via crossref
- doi:10.4049/jimmunol.175.7.4199 via crossref
- doi:10.1038/ni.3456 via crossref
- doi:10.3389/fimmu.2018.00045 via crossref
- doi:10.4049/jimmunol.182.2.751 via crossref
- doi:10.1101/gad.1793709 via crossref
- doi:10.1016/j.immuni.2012.08.009 via crossref
- doi:10.1074/jbc.ra118.006374 via crossref
- doi:10.1021/acs.jmedchem.0c01782 via crossref
- doi:10.1128/mcb.01154-06 via crossref
- doi:10.1158/2159-8290.cd-16-1020 via crossref
- doi:10.1038/s41577-021-00563-6 via crossref
Source provenance
- crossref
- last seen: 2026-07-02T06:26:58.918560+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-ND-4.0